LLY Healthcare
Eli Lilly & Co.
$993.64
%
($)
Valuation Metrics
| P/E Trailing | 48.78 |
| P/E Forward | 30.73 |
| PEG Ratio | -- |
| Market Cap | $890.76B |
| Price Target | $1072.04 (+7.9%) |
Balance Sheet
| D/E Ratio | 178.52 |
| Current Ratio | 1.55 |
| Cash | $9.91B |
| Total Debt | $42.58B |
| Net Cash | $-32.66B |
Profitability
| Gross Margin | 83.03% |
| Operating Margin | 48.29% |
| Net Margin | 30.99% |
| ROE | 96.47% |
| FCF | $1.40B |
Scores
| GF Score | -- |
| Altman Z-Score | -- |
| Piotroski F-Score | -- |
| Div. Yield | 63.00% |
| Analyst Rating | buy |
Analysis & Conclusion
BULLISH
HOLD: High leverage - monitor debt levels. Strong profitability with 96.5% ROE. 63.00% dividend yield provides income.
Recent News
MarketWatch •
MarketWatch •
MarketWatch •
MarketWatch •
MarketWatch •
MarketWatch •